Revance Therapeutic (RVNC) PT Lowered to $40 at Stifel
Tweet
Share
E-mailGet Alerts RVNC Hot Sheet
Price: $3.65 --0%
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Annabel Samimy lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $40.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
